Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...
Abstract: Millimeter wave (mmWave) wireless communications are significant technologies that support Internet of Things (IoT) systems to achieve fast and stable data transmission, and the guarantee of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback